Follow The Filings

GRCE Grace Therapeutics

Grace Therapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2027 Q1 13 Aug EPS — -0.91 —
Rev — — —

Insider trades

Open-market buys and sales by GRCE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GRCE insider trades
  • $616K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Opaleye Management Inc. 10% owner
    Buy
    $8,001 4,256 shares at $1.88 +0.1% to stake
    Traded Oct 19 Filed Oct 21
    ↗
  2. Opaleye Management Inc. 10% owner
    Buy
    $136K 71,065 shares at $1.92 +2.5% to stake
    Traded Oct 14–16 Filed Oct 16
    ↗
  3. Opaleye Management Inc. 10% owner
    Buy
    $30K 14,632 shares at $2.03 +0.5% to stake
    Traded Oct 8–12 Filed Oct 13
    ↗
  4. Opaleye Management Inc. 10% owner
    Buy
    $124K 60,490 shares at $2.05 +2.2% to stake
    Traded Oct 1–5 Filed Oct 5
    ↗
  5. Opaleye Management Inc. 10% owner
    Buy
    $16K 7,849 shares at $2.09 +0.3% to stake
    Traded Sep 29 Filed Oct 1
    ↗
  6. Opaleye Management Inc. 10% owner
    Buy
    $32K 15,089 shares at $2.10 +0.5% to stake
    Traded Sep 21–23 Filed Oct 1
    ↗
  7. Opaleye Management Inc. 10% owner
    Buy
    $32K 15,229 shares at $2.09 +0.6% to stake
    Traded Sep 8–9 Filed Sep 10
    ↗
  8. Prashant Kohli CEO
    Buy
    $214K 100,000 shares at $2.14 +468% to stake
    Traded Sep 9 Filed Sep 10
    ↗
  9. Opaleye Management Inc. 10% owner
    Buy
    $24K 11,608 shares at $2.09 +0.4% to stake
    Traded Aug 14 Filed Aug 19
    ↗

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.